PLAINSBORO, N.J., March 19, 2026 /PRNewswire/ -- Novo Nordisk today announced US Food and Drug Administration (FDA) approval of a new higher dose of Wegovy®, Wegovy® HD (semaglutide) injection 7.2 mg, ...
Based on a mean baseline body weight of 248 lb. for Wegovy® injection 7.2 mg and placebo groups, and 257 lb. for the Wegovy® 2.4 mg group. * Based on the efficacy estimand: estimated efficacy in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results